LEOCOR SABLE(TM) PTCA CATHETER

FDA Premarket Approval P890001 S020

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Modified device packaging for all leocor's currently marketed ptca catheters.

DeviceLEOCOR SABLE(TM) PTCA CATHETER
Generic NameCatheters, Transluminal Coronary Angioplasty, Percutaneous
ApplicantLEOCOR, INC.
Date Received1996-11-29
Decision Date1997-01-16
PMAP890001
SupplementS020
Product CodeLOX 
Advisory CommitteeCardiovascular
Supplement TypeNormal 180 Day Track
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product No
Applicant Address LEOCOR, INC. 1301 Regents Pk. Dr. houston, TX 77058

Supplemental Filings

Supplement NumberDateSupplement Type
P890001Original Filing
S020 1996-11-29 Normal 180 Day Track
S019 1996-10-03 Normal 180 Day Track
S018 1996-09-09 Normal 180 Day Track
S017
S016 1996-04-18 Normal 180 Day Track
S015 1995-12-01 Normal 180 Day Track
S014 1995-06-21 30-Day Supplement
S013
S012 1995-03-03 30-Day Supplement
S011 1994-09-01 Normal 180 Day Track
S010 1993-10-07 Normal 180 Day Track
S009 1993-09-16 Normal 180 Day Track
S008
S007 1991-12-23 Normal 180 Day Track
S006 1991-09-27 Normal 180 Day Track
S005 1991-05-14 Normal 180 Day Track
S004 1990-10-15 Normal 180 Day Track
S003 1990-02-14 Normal 180 Day Track
S002 1990-05-17 Panel Track
S001 1990-04-10 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.